Detalhe da pesquisa
1.
Contributions of hepatic gluconeogenesis suppression and compensative glycogenolysis on the glucose-lowering effect of CS-917, a fructose 1,6-bisphosphatase inhibitor, in non-obese type 2 diabetes Goto-Kakizaki rats.
J Pharmacol Sci
; 115(3): 329-35, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21350313
2.
Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
Eur J Pharmacol
; 623(1-3): 141-7, 2009 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19765581
3.
CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats.
Eur J Pharmacol
; 601(1-3): 192-7, 2008 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-19014931
4.
Synthesis and biological activity of novel alpha-substituted beta-phenylpropionic acids having pyridin-2-ylphenyl moiety as antihyperglycemic agents.
Bioorg Med Chem
; 12(9): 2419-39, 2004 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15080938